Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Inherited Metabolic Diseases, |
RCV000985005 | SCV001554468 | pathogenic | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2021-04-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000985005 | SCV003492437 | pathogenic | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 227 of the MTHFR protein (p.Thr227Met). This variant is present in population databases (rs748571395, gnomAD 0.008%). This missense change has been observed in individual(s) with MTHFR deficiency (PMID: 7726158, 32939339; Invitae; external communication). This variant is also known as C692T. ClinVar contains an entry for this variant (Variation ID: 800827). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MTHFR protein function. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000985005 | SCV003808995 | uncertain significance | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2021-08-31 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003461295 | SCV004196391 | pathogenic | Neural tube defects, folate-sensitive | 2023-10-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000985005 | SCV005077183 | pathogenic | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2024-04-19 | criteria provided, single submitter | clinical testing | Variant summary: MTHFR c.680C>T (p.Thr227Met), also reported as "C692T", results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251488 control chromosomes. c.680C>T has been reported in the literature in multiple homozygous individuals affected with Homocystinuria due to Methylene Tetrahydrofolate Reductase Deficiency (examples: Aljassim_2020, Goyette_1995). These data indicate that the variant is very likely to be associated with disease. At least one publication reports that enzyme activity in patient fibroblasts was <10% of normal activity (Goyette_1995). The following publications have been ascertained in the context of this evaluation (PMID: 32939339, 7726158). ClinVar contains an entry for this variant (Variation ID: 800827). Based on the evidence outlined above, the variant was classified as pathogenic. |
Biochemical Molecular Genetic Laboratory, |
RCV000985005 | SCV001132934 | pathogenic | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2019-08-25 | no assertion criteria provided | clinical testing |